Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | WT1 |
| Upstream (Parents) |
|---|
| (<<) HR → WT1 |
| (<<) TCF21 → WT1 |
| (<<) MSX1 → WT1 |
| (<<) VDR → WT1 |
| (<<) SNAI2 → WT1 |
| (<<) NR4A2 → WT1 |
| (<<) ELF3 → WT1 |
| (<<) C11orf9 → WT1 |
| (<<) ZNF83 → WT1 |
| (<<) BCL11B → WT1 |
| (<<) JUND → WT1 |
| Downstream (Children) |
|---|
| WT1 → NPAS1 (>>) |
| WT1 → TLX1 (>>) |
| WT1 → POU3F1 (>>) |
| WT1 → FOSB (>>) |
| WT1 → PHOX2A (>>) |
| WT1 → TAL1 (>>) |
| WT1 → LHX3 (>>) |
| WT1 → NFYA (>>) |
| WT1 → CREB5 (>>) |
| WT1 → E2F4 (>>) |
| WT1 → ARNTL2 (>>) |
